PHASE I WILL INVOLVE ASCERTAINING THE FEASIBILITY OF A NOVEL ELECTROCHEMICAL IMMUNOSENSOR APPROACH.

Award Information
Agency:
Department of Health and Human Services
Branch:
N/A
Amount:
$49,951.00
Award Year:
1985
Program:
SBIR
Phase:
Phase I
Contract:
N/A
Agency Tracking Number:
2931
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Biotech Research Laboratories
1600 E. Gude Drive, Rockville, MD, 20850
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
N/A
Principal Investigator
 ANTON F. STEUER
 PRINCIPAL INVESTIGATOR
 (301) 251-0800
Business Contact
Phone: () -
Research Institution
N/A
Abstract
PHASE I WILL INVOLVE ASCERTAINING THE FEASIBILITY OF A NOVEL ELECTROCHEMICAL IMMUNOSENSOR APPROACH. ELECTRODES IN SERIES AND WITH ELECTROACTIVE REAGENTS WILL BE CONSTRUCTED AND EVALUATED FOR THEIR ABILITY TO DETECT HAPTENS AND ANTIGENS SUCH AS AFLATOXIN B1 AND HTLV-III. AN ELECTROCHEMICAL IMMUNOSENSOR OR ANTIBODY ELECTRODE THAT IS FAST, RELIABLE, AND SENSITIVE WILL HAVE MANY VALUABLE COMMERCIAL APPLICATIONS IN THE FIELDS OF CLINICAL CHEMISTRY, BIOTECHNOLOGY, THE FOOD INDUSTRY, AND OTHER COMMERCIAL AND RESEARCH FIELDS. PHASE II WILL INVOLVE THE DEVELOPMENT OF A PROTOTYPE ELECTRODE FOR COMMERCIALIZATION.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government